VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3605
+0.0002 (0.06%)
Nov 20, 2025, 8:16 AM EST - Market open
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $12 million as of November 20, 2025. Its market cap has decreased by -72.79% in one year.
Market Cap
12.00M
Enterprise Value
-20.71M
1-Year Change
-72.79%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $12.00M, a decrease of -94.78%. That is a compound annual growth rate of -40.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 11.99M | -75.73% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 926.11B |
| Johnson & Johnson | 479.96B |
| AbbVie | 415.03B |
| UnitedHealth Group | 281.12B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 239.33B |
| Abbott Laboratories | 226.19B |